Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
M., Bonelli, M., Gadina, M
Ethanolic extract of Iris songarica rhizome attenuates methotrexate-induced liver and kidney damages in rats
Malignant hyperthermia susceptibility revealed by increased serum creatine kinase concentrations during statin treatment
Monpellier, V
The Triple-Agonist Breakthrough Retatrutide (LY3437943), developed by Eli Lilly, is an investigational triple-agonist peptide that activates three metabolic receptors simultaneously: GLP-1, GIP, and the glucagon receptor
US$ 24.54
US$ 25.89
US$ 29.28
US$ 21.77
US$ 27.06
US$ 23.30
US$ 21.29
US$ 20.34
US$ 26.94
